Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2884 participants.

Also called NCT01293097

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,884 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01293097
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01293097. Randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2011-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
Acronym
ISCAP
Condition
Non-ST Segment Elevation Myocardial Infarction
Condition
Unstable Angina Pectoris
Condition
Stable Angina Pectoris
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Statin
Lead sponsor
Peking University First Hospital (class: other)

Record details

Record id
cardio:ct-nct01293097
Content hash
c04c178e3a2800396f1bcc4da424cc78ccc0a0873c7355faa6c864b291c1c21d